Common research protocols cited in the peptide community use 1 to 2 mg, 3 to 5 times weekly, over 8 to 12-week cycles
GLP-1 receptor agonists (for example, semaglutide) enhance insulin secretion, suppress glucagon, slow gastric emptying, and act centrally to improve satiety
With cellular maintenance on overdrive, the organism can continue to protect itself from chronic inflammation, which causes a range of serious illnesses, particularly aging-related diseases
Research & Clinical Studies Key Findings From Research on AOD-9604 Designed to isolate fat-burning properties of HGH Studied for obesity and fat metabolism support Appears metabolically neutral regarding glucose and IGF-1 Demonstrated lipolytic activity in preclinical models Explored for cartilage and joint support applications Studied as part of body composition and metabolic optimization strategies Heffernan M, Summers RJ, Thorburn A, Ogru E, Gianello R, Jiang WJ, Ng FM
Air exposure increases oxidation
